MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$2,512,216
(-8.11%↓ Y/Y)
Product
$3,088,509
License
$225,000
Loss before benefit
for income taxes
-$2,512,216
(-8.11%↓ Y/Y)
Other income
$5,237
(1202.74%↑ Y/Y)
Revenue
$3,313,509
(142.72%↑ Y/Y)
Loss from operations
-$2,516,649
(-2.39%↓ Y/Y)
Us-gaap_grossprofit
$2,217,956
(108.78%↑ Y/Y)
Interest income
(expense), net
-$804
(-865.71%↓ Y/Y)
Costs of sales
$1,095,553
(261.76%↑ Y/Y)
Total operating
expenses
$4,734,605
(34.50%↑ Y/Y)
Selling, general and
administrative
$4,734,605
(34.50%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)